It’s the day after the Baltimore Orioles clinched the American League East Championship with their 100th win of the season, and lifelong fan Tim Evans...
Being open to the possibility you could be wrong about your beliefs is an important part of learning about the world. But this trait is not...
GigXR, Inc., a global provider of holographic healthcare training, announced today its partnership with the Yong Loo Lin School of Medicine, National University...
Authorities have put a pause on one company wreaking havoc on the roads.
When family members of patients with colorectal cancer are invited to screening appointments themselves, just 1 in 3 go ahead with either fecal testing...
The U.S. Department of Commerce and its Economic Development Administration (EDA) on Monday recognized two University of Notre Dame programs with a development...
UK data roughly in line but downside risks remain It’s been another mixed session on Tuesday with investors potentially eyeing important events later...
Novo Nordisk’s Rybelsus pill was long expected to be a hit out of the gate. The Danish drugmaker cashed in a priority review voucher in early...
Children in child care centers are not spreading COVID-19 at significant rates to caregivers or other children at the center, nor to their households,...
The promise of human organotypic tissues for tissue development, disease modelling, and drug testing is widely recognized, but limitations around cell...
The "pain trade" continues to be higher into year-end. We made Such a point in January, suggesting the 2022 "correction" was complete. Let's review what...
Japanese PMI point to softness in manufacturing and services Speculation rises that BoJ could tweak yield control policy The Japanese yen has edged higher...
War Wakes Up Gold Authored by Alasdair Macleod via GoldSchiff.com, Last week, a firmer trend in gold continued as markets realized the seriousness...
A pullback in Treasury yields has stocks moving higher Monday heading into a busy earnings week and a key 2-year bond auction later on Tuesday.
It’s a year since Elon Musk took charge of Twitter. His plan for charging new customers looks like another mis-step.
Japan has undertaken extensive efforts to decontaminate land in Fukushima – whether they were they right to do so is a complex question.
Researchers at ETH Zurich in Switzerland have developed an alternative to injections as a way to deliver large drugs, such as peptides, minimally invasively...
MADRID — When Daiichi Sankyo scientists pushed forward with antibody-drug conjugate research nearly a decade ago, the program had a lot of naysayers,...
I've been looking for the market to bottom for several weeks. But the trading environment has shifted to a new gear; a cautionary one. On the...
The headline practically screamed: “30 New Orleans area restaurants fail health inspection, some for bugs or dirty kitchens.” Undoubtedly, many people...
The US dollar was mixed last week. One would have thought, based on the geopolitical tensions, the stronger than expected US economic data resulted in...
Cannabis use, even for medical purposes, could make some people sick due to harmful fungi that contaminate the plants. Credit: Photo from Frontiers in...
Key Takeaways Credit: American College of Surgeons Key Takeaways A cancer survival calculator prototype developed with machine learning showed that...
The train network's new ticket structure is coming into effect before the end of 2023.
Stimulating muscle fibers with magnets causes them to grow in the same direction, aligning muscle cells within tissue, Massachusetts Institute of Technology...
They published their work on Oct. 18 in Energy Material Advances. Credit: [Chuang Yu, Huazhong University of Science and Technology] They published their...
Researchers developed a technology called TEMPO, which integrates microvolume liquid-biopsy proteomics, single-cell transcriptomics, and AI, to map almost...
Canada to release retail sales later today Fed’s Powell says inflation still too high, lower growth needed The Canadian dollar has edged higher on Friday....
The COVID Gravy Train Is Over: Pfizer & Moderna Shares Down 35% & 49% This Year It took what felt like forever, but at least some reality...
It’s everything I hoped it would be.